Please assess the completion status of the following clinical trial:

Trial Title: Zinc Sulfate in the Treatment of Rosacea: A Randomized, Controlled Trial

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: TRIPLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Diagnosis of facial rosacea made or confirmed by one of the investigators.~* Severity of signs of rosacea greater than mild at the time of enrollment.~Exclusion Criteria:~* Treatment for rosacea during the 3 months prior to enrollment.~* Use of zinc dietary supplement \> 25 mg per day during the 3 months prior to enrollment ( Most patients taking multivitamins with Zinc, often 15 mg per day, will not be excluded, whereas most patients taking additional Zinc supplements, often 25-50 mg per day or more will be excluded.)~* Diagnosis of rosacea fulminancy.~* Pregnant or breast feeding.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: t

Study Arms:
- Zinc sulfate (Type: EXPERIMENTAL): 220 mg of zinc sulfate
- Lactose (Type: PLACEBO_COMPARATOR): 270 mg lactose

Based on this trial design, predict the completion outcome and termination type (if applicable).